Team
Leadership & Scientific


Founder & Chair
Arezou A. Ghazani, MSc, PhD, DABMGG, FACMG
Dr. Ghazani is a medical geneticist and scientist with expertise in clinical and molecular genomics, constitutional cancer, tumorigenesis, and precision oncology. She has led the development of several programs and genomic tools and methods to identify actionable genetic alterations in cancer. Emphasis is on using an integrated approach in the evaluation of somatic (tumor) and germline (constitutional) genomic data to inform the role of germline alterations and their effect on the clinical management of cancer patients.
Her passion for bridging scientific advances with current clinical needs led to the establishment and development of the INT²GRATE Programs, INT²GRATE Oncology Consortium, and INT²GRATE Variant Data Portal. The INT²GRATE Programs leverage tumor-derived signature profiles and clinical genetic information to identify clinically actionable germline alterations in cancer patients. The INT²GRATE Oncology Consortium is a multi-institutional initiative dedicated to sharing INT²GRATE Variants with their comprehensive tumor-derived and clinical evidence. INT²GRATE Variant Data Portal is a publicly available platform providing access to INT²GRATE Variants. Dr. Ghazani is the Founding Executive Director of the INT²GRATE Programs and the INT²GRATE Variant Data Portal, and Chair of the INT²GRATE Oncology Consortium.


Alison Schwartz
Levine, MS, LGC
Clinical Genetics






Lead Computational Engineer & Developer


Bioinformatian




Connor Hayes, MS
Data Wrangler
Busra Unal, MD
Data Science
Data Scientist
Monica Devi Manam, MS







